Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors

被引:31
作者
Christopoulos, A
Sorman, JL
Mitchelson, F
El-Fakahany, EE
机构
[1] Univ Minnesota, Sch Med, Div Neurosci Res Psychiat, Minneapolis, MN 55455 USA
[2] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut Biol & Pharmacol, Parkville, Vic 3052, Australia
关键词
muscarinic receptors; allosteric modulation; equilibrium binding; dissociation kinetics; cooperativity;
D O I
10.1016/S0006-2952(98)00277-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigated the interaction between the muscarinic acetylcholine receptor (mAChR) allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (C-7/3phth) and the orthosteric antagonist [H-3]N-methylscopolamine ([H-3]NMS) at the five cloned human mAChRs expressed in Chinese hamster ovary cells. Equilibrium binding studies, using two different concentrations of radioligand, showed the interaction between C-7/3phth and [3H]NMS to be characterized by different degrees of negative cooperativity, depending on the receptor subtype. The modulator exhibited the highest affinity (85 nM) for the unoccupied M-2 receptor and the lowest affinity for the unoccupied M-5 receptor, the latter being approximately 100-fold lower. In contrast, the highest degree of negative cooperativity was observed at the M-5 receptor, whereas lowest negative cooperativity was found at the M-1 and M-4 receptors. Non equilibrium dissociation kinetic studies also confirmed the allosteric properties of C-7/3-phth at all five mAChRs and yielded independent estimates of the modulator affinity for the occupied receptor. The latter estimates showed good agreement with those calculated using parameter Values determined from the equilibrium experiments. The present results extend previous findings that C-7/3-phth is a potent allosteric modulator at mAChRs, particularly the M-2 subtype, and also highlight the effects of cooperativity on apparent drug-receptor subtype selectivity. BIOCHEM PHARMACOL 51;2:171-179, 1999. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 36 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] CHARACTERIZATION OF THE ANTIMUSCARINIC EFFECT OF HEPTANE-1,7-BIS-(DIMETHYL-3'-PHTHALIMIDOPROPYL AMMONIUM BROMIDE)
    CHOO, LK
    MITCHELSON, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (03) : 429 - 435
  • [3] Kinetic studies of co-operativity at atrial muscarinic M(2) receptors with an ''infinite dilution'' procedure
    Christopoulos, A
    Lanzafame, A
    Ziegler, A
    Mitchelson, F
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) : 795 - 800
  • [4] BINDING OF THE MUSCARINE RECEPTOR ANTAGONIST HEPTANE-1,7-BIS(DIMETHYL-3'-PHTHALIMIDOPROPYL)AMMONIUM BROMIDE AT CHOLINOCEPTOR SITES
    CHRISTOPOULOS, A
    LOIACONO, R
    MITCHELSON, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 246 (01): : 1 - 8
  • [5] CHRISTOPOULOS A, 1994, MOL PHARMACOL, V46, P105
  • [6] Allosteric interactions at muscarinic cholinoceptors
    Christopoulos, A
    Lanzafame, A
    Mitchelson, F
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (3-4) : 185 - 194
  • [7] EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
  • [8] ALLOSTERIC REGULATION OF CLONED M1-M5 MUSCARINIC RECEPTOR SUBTYPES
    ELLIS, J
    HUYLER, J
    BRANN, MR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 42 (10) : 1927 - 1932
  • [9] ELLIS J, 1992, MOL PHARMACOL, V42, P638
  • [10] Ellis J, 1997, DRUG DEVELOP RES, V40, P193